A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to test the efficacy of the combination treatment AllQbG10 in
patients with perennial allergic rhinoconjunctivitis due to house dust mite allergy in a
double-blind placebo-controlled setting